本页面由Tiger Trade Technology Pte. Ltd.提供服务

燃石医学

30.00
+0.01000.03%
成交量:173.00
成交额:4,937.30
市值:3.23亿
市盈率:-18.45
高:30.00
开:30.00
低:30.00
收:29.99
52周最高:41.72
52周最低:2.18
股本:1,076.66万
流通股本:483.30万
量比:0.07
换手率:0.00%
股息:- -
股息率:- -
每股收益(TTM):-1.6264
每股收益(LYR):-4.6135
净资产收益率:-20.25%
总资产收益率:-6.23%
市净率:4.05
市盈率(LYR):-6.50

数据加载中...

2025/04/29

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/26

SEC问询函

Form CORRESP - Correspondence
2024/11/26

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/04/29

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/10

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/30

SEC问询函

Form CORRESP - Correspondence
2023/08/11

SEC问询函

Form CORRESP - Correspondence
2023/04/20

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/02

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/09/28

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/20

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/12

SEC问询函

CORRESP [Cover] - Correspondence